EFFICIENCY OF ADJUVANT XELOX CHEMOTHERAPY FOR PATIENTS WITH RESECTABLE GASTRIC IN RUSSIA (SINGLE INSTITUTION RETROSPECTIVE STUDY). (2019). Voprosy Onkologii, 65(2), 256-262. https://doi.org/10.37469/0507-3758-2019-65-2-256-262